Two out of the four RBP transcripts found upregulated in PSC and CCA in the present review, namely, ASPM and FANCD2, are indeed promising as potential biomarkers of PSC, as they show significant upregulation in expression also in PSC body fluids with respect to that of healthy controls. The gene discussed is ASPM; the disease is cholangiocarcinoma.